ArticleBMC pregnancy and childbirth2026
Development and internal validation of a predictive model for intrapartum hypertension: a retrospective case-control study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIntrapartum hypertension is associated with adverse outcomes, yet tools for its prediction are limited. This study aimed to develop a predictive model using routine clinical data.
methodsThis retrospective case-control study included 200 women, comprising 100 with intrapartum hypertension and 100 matched controls. We developed a predictive model by first screening candidate variables through univariate analysis. Variables that showed significant differences were then entered into a multivariate logistic regression model to identify independent predictors. The model’s performance was evaluated using the area under the receiver operating characteristic curve (AUC). Internal validation was conducted via the bootstrap method with 500 resamples to correct for optimism and to estimate a more generalizable AUC. Intrapartum hypertension was defined as a systolic blood pressure ≥ 140 mmHg or a diastolic blood pressure ≥ 90 mmHg during labor, confirmed on two separate occasions. Risk factors were identified using univariate and multivariate logistic regression, and predictive performance was assessed by ROC analysis.
resultsThe case group exhibited higher rates of cesarean delivery (14% vs. 4%), higher peak blood pressure, and greater neonatal birth weight (all P < 0.05). Independent risk factors identified were elevated lactate dehydrogenase (LDH), higher admission weight, gestational diabetes mellitus, proteinuria in the second trimester or antenatal period (all P < 0.05). The final multivariate model achieved an AUC of 0.832. After bootstrap internal validation, the optimism-corrected AUC was 0.815.
conclusionA model incorporating five routinely available clinical parameters (including lactate dehydrogenase level, admission weight, gestational diabetes mellitus, and second-trimester or antenatal proteinuria) effectively identifies parturients at high risk for developing intrapartum hypertension. This tool can facilitate early, targeted monitoring in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.